Digipath (OTCMKTS:DIGP) and ICF International (NASDAQ:ICFI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.
Volatility and Risk
Digipath has a beta of 4.99, suggesting that its stock price is 399% more volatile than the S&P 500. Comparatively, ICF International has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500.
ICF International pays an annual dividend of $0.56 per share and has a dividend yield of 0.8%. Digipath does not pay a dividend. ICF International pays out 18.5% of its earnings in the form of a dividend.
This table compares Digipath and ICF International’s net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets Digipath -58.20% -126.57% -103.96% ICF International 5.45% 10.24% 5.69%
This is a breakdown of recent recommendations for Digipath and ICF International, as provided by MarketBeat.com.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Digipath 0 0 0 0 N/A ICF International 0 3 3 0 2.50
ICF International has a consensus target price of $78.33, suggesting a potential upside of 5.78%. Given ICF International’s higher probable upside, analysts plainly believe ICF International is more favorable than Digipath.
Earnings & Valuation
This table compares Digipath and ICF International’s gross revenue, earnings per share and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Digipath $2.84 million 3.25 -$1.65 million N/A N/A ICF International $1.23 billion 1.14 $62.87 million $3.02 24.52
ICF International has higher revenue and earnings than Digipath.
Institutional & Insider Ownership
0.5% of Digipath shares are held by institutional investors. Comparatively, 91.0%